Eszopiclone



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 80.0%
Insomnia 12.6%
Depression 6.3%
Sleep Study 1.1%
Completed Suicide 48.0%
Insomnia 8.0%
Major Depression 8.0%
Cardio-respiratory Arrest 4.0%
Dyspnoea 4.0%
Hallucination 4.0%
Incoherent 4.0%
Mental Status Changes 4.0%
Psychotic Disorder 4.0%
Reflux Oesophagitis 4.0%
Type 1 Diabetes Mellitus 4.0%
Vasospasm 4.0%
Secondary
Product Used For Unknown Indication 48.9%
Drug Use For Unknown Indication 27.4%
Insomnia 4.3%
Suicide Attempt 4.3%
Completed Suicide 3.1%
Nightmare 1.9%
Anxiety 1.5%
Major Depression 1.5%
Suicidal Ideation 1.5%
Depression 1.2%
Hallucination, Auditory 1.2%
Metastatic Malignant Melanoma 1.0%
Rheumatoid Arthritis 1.0%
Bursitis 0.4%
Psychotic Disorder 0.3%
Ear Infection 0.1%
Hormone Replacement Therapy 0.1%
Initial Insomnia 0.1%
Middle Insomnia 0.1%
Completed Suicide 39.0%
Respiratory Arrest 16.5%
Toxicity To Various Agents 7.5%
Poisoning 4.5%
Weight Increased 4.5%
Cardio-respiratory Arrest 4.0%
Death 4.0%
Thrombocytopenia 4.0%
Cardiac Arrest 2.0%
Drug Toxicity 2.0%
Mental Status Changes 2.0%
Sciatic Nerve Palsy 2.0%
Incoherent 1.5%
Intentional Drug Misuse 1.5%
Psychotic Disorder 1.5%
Middle Insomnia 1.0%
Toxic Encephalopathy 1.0%
Blood Bilirubin Increased 0.5%
Blood Creatine Phosphokinase Increased 0.5%
Cardiac Failure 0.5%
Concomitant
Product Used For Unknown Indication 40.0%
Drug Use For Unknown Indication 28.1%
Depression 5.4%
Pain 3.4%
Insomnia 3.4%
Anxiety 3.0%
Rheumatoid Arthritis 2.6%
Hypertension 2.6%
Crohn's Disease 1.8%
Peritoneal Dialysis 1.2%
Gastrooesophageal Reflux Disease 1.0%
Hepatitis C 1.0%
Nausea 1.0%
Sleep Disorder 0.9%
Thrombosis Prophylaxis 0.9%
Type 2 Diabetes Mellitus 0.8%
Diffuse Large B-cell Lymphoma 0.7%
Blood Pressure 0.7%
Chest Pain 0.7%
Mineral Supplementation 0.7%
Vomiting 20.5%
Encephalopathy 8.4%
X-ray Abnormal 7.2%
Pneumonia 6.0%
Tremor 6.0%
Weight Decreased 4.8%
Wound Dehiscence 4.8%
Delirium 3.6%
Dyspnoea 3.6%
Hypersensitivity 3.6%
Pruritus 3.6%
Pulmonary Embolism 3.6%
Pyrexia 3.6%
Tooth Extraction 3.6%
Vein Disorder 3.6%
White Blood Cell Count Decreased 3.6%
Adverse Drug Reaction 2.4%
Asthenia 2.4%
Cardio-respiratory Arrest 2.4%
Cellulitis 2.4%
Interacting
Pulmonary Arterial Hypertension 100.0%
Viral Infection 100.0%